Compounded Medicine
The quiet, unglamorous layer of the market that most patients are actually on.
Compounded medications sit in the structural seam between the branded pharmaceutical market and the out-of-pocket telehealth economy. This desk follows the FDA enforcement, the 503A/503B distinction, the pricing, and the quality questions that most patients never think to ask.
This Week's Feature
Hand-picked by the desk.
Compounded vs. Brand-Name GLP-1s: What's Actually Different
A plain-language guide to how compounded semaglutide and tirzepatide differ from their FDA-approved counterparts — in the evidence behind them, the oversight they get, and the risks they carry.
Read the feature →